We use cookies to ensure that we give you the best experience on our website Learn more

May 9, 2019

16th World Congress of the European Association for Palliative Care

A Program of Study to Increase Research Access and Participation by Children and Young People with Life-limiting Conditions and Life-threatening Illnesses and their Families: Barriers to Research Access: Voices, Experiences and Solutions. The BRAVES Project

barriers to research

life-limiting conditions

life-threatening illnesses

Abstract

Abstract

thumbnail

Keywords

barriers to research

life-limiting conditions

life-threatening illnesses

Abstract

Background: Previous studies have found clinician gatekeeping to be a major barrier to research participation for children and young people with life-limiting conditions and life-threatening illnesses (CYP with LLC/LTI). Little is known about other barriers to research with CYP with LLC/LTI and their impact. Aims: BRAVES is a program of research aiming 1) to explore barriers to conducting research with CYP with LLC/LTI 2) to develop solutions for overcoming these barriers. Methods: The programme includes five work packages (WP): (1) A systematic review investigating recruitment of CYP with LLC/LTI to research; (2) A survey exploring views of paediatric palliative care (PPC) clinicians on barriers to research with CYP; (3) A national survey exploring the difficulties and solutions proposed by chief investigators' conducting studies with CYP with LLC/LTI; (4) An analysis of correspondence between researchers conducting studies with CYP with LLC/LTI and research ethics committees (RECs); (5) Interviews with REC members to understand their experience of reviewing research with this population. Results: Findings from three WP completed to date indicate that: (1) recruitment information is consistently under-reported (WP1); (2) PPC clinicians identify the REC review process; time and resources as well as clinician gatekeeping as barriers to research (WP 2) and chief investigators identify funding, access to families, and ethical and regulatory approval as barriers to research with CYP with LLC/LTI (WP 3). Conclusion: Clinician gatekeeping is a barrier to research with CYP with LLC/LTIs but other barriers include resources and the ethical/regulatory approval process. Findings from BRAVES will contribute to the development of guidance for overcoming such barriers. Funding: This research is funded by NIHR CLAHRC,The Health Foundation, GOSH Children´s Charity,NIHR-GOSH BRC &The True Colors Trust.

Discover over 20,000 new abstracts, posters and presentations from leading academic conferences every month. Stay on top of the latest findings, methodologies and discussions happening in your research field around the world.

Company

Legal

Follow us

© Copyright 2019 Morressier GmbH. All rights reserved.

© Copyright 2019 Morressier GmbH.
All rights reserved.